Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by Bridgewater Associates LP

Bridgewater Associates LP lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 4.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 294,827 shares of the company’s stock after acquiring an additional 13,225 shares during the quarter. Bridgewater Associates LP’s holdings in Bath & Body Works were worth $9,411,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. First Community Trust NA acquired a new stake in Bath & Body Works in the second quarter valued at $30,000. Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares during the last quarter. Meeder Asset Management Inc. raised its stake in shares of Bath & Body Works by 480.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,436 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Bath & Body Works by 65.4% during the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after purchasing an additional 730 shares during the last quarter. Finally, Abich Financial Wealth Management LLC acquired a new position in Bath & Body Works in the third quarter worth about $103,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insider Activity

In other news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction dated Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This represents a 2.53 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.27% of the company’s stock.

Bath & Body Works Price Performance

BBWI opened at $35.90 on Friday. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The stock’s 50 day moving average price is $30.93 and its 200 day moving average price is $35.65. The stock has a market cap of $7.87 billion, a P/E ratio of 8.76, a P/E/G ratio of 1.14 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Equities analysts anticipate that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Wall Street Analyst Weigh In

BBWI has been the topic of several research reports. BMO Capital Markets restated an “outperform” rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Telsey Advisory Group reissued an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday. Evercore ISI decreased their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. The Goldman Sachs Group dropped their target price on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Finally, Raymond James decreased their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.